B. Riley Financial, Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 20 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
B. Riley Financial, Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2016$72,000
+46.9%
74,000
+48.0%
0.05%
+54.8%
Q3 2016$49,000
+4.3%
50,0000.0%0.03%
+14.8%
Q2 2016$47,00050,0000.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Pinnacle Summer Investments, Inc. 1,193,517$41,614,0005.12%
BASSO CAPITAL MANAGEMENT, L.P. 13,943,000$13,612,0002.17%
SILVERBACK ASSET MANAGEMENT LLC 8,000,000$7,816,0001.01%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,100,000$7,863,0000.80%
ZAZOVE ASSOCIATES LLC 13,180,000$12,725,0000.52%
LINDEN ADVISORS LP 2,743,000$2,658,0000.50%
IRON Financial LLC 390,000$3,729,0000.38%
ADVENT CAPITAL MANAGEMENT /DE/ 25,114,000$24,280,0000.36%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 26,500,000$25,341,0000.32%
WOLVERINE ASSET MANAGEMENT LLC 11,936,000$11,574,0000.22%
View complete list of PDL BIOPHARMA INC shareholders